CSL (CSL) Share Forecast & Price Target

Compare

792 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CSL Analyst Ratings

Strong Buy

9 Buy

3 Hold

0 Sell

Based on 12 analysts giving stock ratings to

CSL

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CSL Stock 12 Month Forecast

Average Price Target

AU$245.37

▲(31.71% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for CSL in the last 3 months. The average price target is AU$245.37 with a high forecast of AU$284.21 and a low forecast of AU$195.84. The average price target represents a 31.71% change from the last price of AU$186.30.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"177":"AU$177","204":"AU$204","231":"AU$231","258":"AU$258","285":"AU$285"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":284.212197311458,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$284.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":245.3699427725,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$245.37</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":195.83525963157,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$195.84</span>\n  </div></div>","useHTML":true}}],"tickPositions":[177,204,231,258,285],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,178.5,186.63170748549678,194.76341497099355,202.8951224564903,211.02682994198707,219.15853742748385,227.2902449129806,235.42195239847737,243.55365988397415,251.68536736947092,259.8170748549677,267.94878234046445,276.0804898259612,{"y":284.212197311458,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,178.5,183.64384175173078,188.78768350346155,193.9315252551923,199.07536700692307,204.21920875865385,209.36305051038462,214.5068922621154,219.65073401384615,224.79457576557692,229.9384175173077,235.08225926903845,240.22610102076925,{"y":245.3699427725,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,178.5,179.83348151012078,181.16696302024155,182.5004445303623,183.83392604048308,185.16740755060385,186.50088906072463,187.83437057084538,189.16785208096616,190.50133359108693,191.8348151012077,193.16829661132846,194.50177812144923,{"y":195.83525963157,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":276.156,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.186,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":276.117,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":274.989,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":255.515,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":248.673,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":248.228,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":244.946,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":235.496,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":261.009,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":207.848,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetAU$284.21

Average Price TargetAU$245.37

Lowest Price TargetAU$195.84

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Steven Wheen

Jarden

AU$287.14→AU$283

Buy

51.91%

Upside

Reiterated

11/22/25

Jarden Sticks to Its Buy Rating for CSL (CMXHF)

Laura Sutcliffe

Citi

AU$225

Buy

20.77%

Upside

Reiterated

11/16/25

Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF) and Ramsay Health Care (Other OTC: RMSYF)

David Bailey

Morgan Stanley

AU$248→AU$256

Buy

37.41%

Upside

Reiterated

11/14/25

Morgan Stanley Reaffirms Their Buy Rating on CSL (CMXHF)

Craig Wong-Pan

RBC Capital

AU$189→AU$226

Hold

21.31%

Upside

Reiterated

11/06/25

RBC Capital Remains a Hold on CSL (CMXHF)

Marcus Curley

UBS

AU$275

Buy

47.61%

Upside

Reiterated

11/06/25

UBS Sticks to Its Buy Rating for CSL (CMXHF)

Davinthra Thillainathan

Goldman Sachs

AU$311→AU$212.1

Buy

13.85%

Upside

Reiterated

10/29/25

Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

AU$258→AU$235

Hold

26.14%

Upside

Reiterated

10/29/25

Ord Minnett Keeps Their Hold Rating on CSL (CMXHF)

Shane Storey

Canaccord Genuity

AU$230→AU$225

Buy

20.77%

Upside

Upgraded

10/28/25

CSL upgraded to Buy from Hold at CanaccordCSL upgraded to Buy from Hold at Canaccord

Derek Jellinek

Morgans

AU$293.83→AU$249.51

Buy

33.93%

Upside

Reiterated

10/28/25

CSL (CMXHF) Gets a Buy from Morgans

Thomas Wakim

Bell Potter

AU$230→AU$195

Hold

4.67%

Upside

Reiterated

10/28/25

CSL (CMXHF) Gets a Hold from Bell Potter

Unknown Analyst

Macquarie

Not Ranked

Macquarie

AU$295.9→AU$275.2

Buy

47.72%

Upside

Reiterated

10/20/25

Macquarie Keeps Their Buy Rating on CSL (CMXHF)

Andrew Paine

CLSA

AU$315→AU$275

Buy

47.61%

Upside

Reiterated

10/13/25

CLSA Keeps Their Buy Rating on CSL (CMXHF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

AU$258

Hold

38.49%

Upside

Reiterated

09/29/25

CSL (CMXHF) Gets a Hold from Ord Minnett

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

AU$258

Hold

38.49%

Upside

Reiterated

09/16/25

Ord Minnett Sticks to Its Hold Rating for CSL (CMXHF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

AU$258

Hold

38.49%

Upside

Reiterated

09/08/25

Ord Minnett Keeps Their Hold Rating on CSL (CMXHF)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Steven Wheen

Jarden

AU$287.14→AU$283

Buy

51.91%

Upside

Reiterated

11/22/25

Jarden Sticks to Its Buy Rating for CSL (CMXHF)

Laura Sutcliffe

Citi

AU$225

Buy

20.77%

Upside

Reiterated

11/16/25

Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF) and Ramsay Health Care (Other OTC: RMSYF)

David Bailey

Morgan Stanley

AU$248→AU$256

Buy

37.41%

Upside

Reiterated

11/14/25

Morgan Stanley Reaffirms Their Buy Rating on CSL (CMXHF)

Craig Wong-Pan

RBC Capital

AU$189→AU$226

Hold

21.31%

Upside

Reiterated

11/06/25

RBC Capital Remains a Hold on CSL (CMXHF)

Marcus Curley

UBS

AU$275

Buy

47.61%

Upside

Reiterated

11/06/25

UBS Sticks to Its Buy Rating for CSL (CMXHF)

Davinthra Thillainathan

Goldman Sachs

AU$311→AU$212.1

Buy

13.85%

Upside

Reiterated

10/29/25

Goldman Sachs Reaffirms Their Buy Rating on CSL (CMXHF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

AU$258→AU$235

Hold

26.14%

Upside

Reiterated

10/29/25

Ord Minnett Keeps Their Hold Rating on CSL (CMXHF)

Shane Storey

Canaccord Genuity

AU$230→AU$225

Buy

20.77%

Upside

Upgraded

10/28/25

CSL upgraded to Buy from Hold at CanaccordCSL upgraded to Buy from Hold at Canaccord

Derek Jellinek

Morgans

AU$293.83→AU$249.51

Buy

33.93%

Upside

Reiterated

10/28/25

CSL (CMXHF) Gets a Buy from Morgans

Thomas Wakim

Bell Potter

AU$230→AU$195

Hold

4.67%

Upside

Reiterated

10/28/25

CSL (CMXHF) Gets a Hold from Bell Potter

Unknown Analyst

Macquarie

Not Ranked

Macquarie

AU$295.9→AU$275.2

Buy

47.72%

Upside

Reiterated

10/20/25

Macquarie Keeps Their Buy Rating on CSL (CMXHF)

Andrew Paine

CLSA

AU$315→AU$275

Buy

47.61%

Upside

Reiterated

10/13/25

CLSA Keeps Their Buy Rating on CSL (CMXHF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

AU$258

Hold

38.49%

Upside

Reiterated

09/29/25

CSL (CMXHF) Gets a Hold from Ord Minnett

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

AU$258

Hold

38.49%

Upside

Reiterated

09/16/25

Ord Minnett Sticks to Its Hold Rating for CSL (CMXHF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

AU$258

Hold

38.49%

Upside

Reiterated

09/08/25

Ord Minnett Keeps Their Hold Rating on CSL (CMXHF)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CSL

1 Month

xxx

Success Rate

8/17 ratings generated profit

Average Return

-3.35%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 47.06% of your transactions generating a profit, with an average return of -3.35% per trade.

3 Months

xxx

Success Rate

8/23 ratings generated profit

Average Return

-4.10%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 34.78% of your transactions generating a profit, with an average return of -4.10% per trade.

1 Year

Shane StoreyCanaccord Genuity

Success Rate

5/13 ratings generated profit

Average Return

-3.72%

upgraded a buy rating last month

Copying Shane Storey's trades and holding each position for 1 Year would result in 38.46% of your transactions generating a profit, with an average return of -3.72% per trade.

2 Years

xxx

Success Rate

5/13 ratings generated profit

Average Return

-1.08%

upgraded a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 38.46% of your transactions generating a profit, with an average return of -1.08% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CSL Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CSL has received 26 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. CSL average Analyst price target in the past 3 months is 245.37.

Each month's total comprises the sum of three months' worth of ratings.

CSL Financial Forecast

CSL Earnings Forecast

Next quarter’s earnings estimate for CSL is AU$6.52 with a range of AU$5.71 to AU$7.01. The previous quarter’s EPS was AU$3.64. CSL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year CSL has Performed in-line its overall industry.

CSL Sales Forecast

Next quarter’s sales forecast for CSL is AU$13.18B with a range of AU$12.75B to AU$13.52B. The previous quarter’s sales results were AU$11.03B. CSL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year CSL has Performed in-line its overall industry.

CSL Stock Forecast FAQ

What is AU:CSL’s average 12-month price target, according to analysts?

Based on analyst ratings, CSL’s 12-month average price target is 245.37.

What is AU:CSL’s upside potential, based on the analysts’ average price target?

CSL has 31.71% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CSL a Buy, Sell or Hold?

CSL has a consensus rating of Strong Buy, which is based on 9 buy ratings, 3 hold ratings and 0 sell ratings.

What is CSL’s share price target?

The average share price target for CSL is 245.37. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$284.21 ,and the lowest forecast is AU$195.84. The average share price target represents 31.71% Increase from the current price of AU$186.3.

What do analysts say about CSL?

CSL’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of CSL?

To buy shares of AU:CSL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

CSL (CSL) Share Forecast & Price Target

CSL Analyst Ratings

CSL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering CSL

CSL Analyst Recommendation Trends

CSL Financial Forecast

CSL Earnings Forecast

CSL Sales Forecast

CSL Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts